|Podcasts|January 7, 2021
Episode 73: Biotech’s IPO Steamroll
Author(s)Elaine Quilici
Gregg Beloff, co-founder of Danforth Advisors, discusses the banner year biotech IPOs had in 2020, the drive behind that boom, and what the future of industry IPOs might look like.
Advertisement
Gregg Beloff, co-founder of Danforth Advisors, discusses the banner year biotech IPOs had in 2020, the drive behind that boom, and what the future of industry IPOs might look like.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Responds to FDA’s Warning Letter Regarding 2025 PADE Inspection
2
Senate Democrats Expand Efforts to Expose Details of MFN Pharma Deals
3
When Ambition Meets Ambiguity: The Trends and Sentiments Shaping Biotech in 2026
4
JCA vs. Reality: Europe’s Push for Clinical Harmonization
5